The National Institute on Drug Abuse (NIDA), as part of the NIH HEAL Initiative, is offering the HEAL Data2Action (D2A) Innovation and Acceleration Projects grant. This phased award aims to support local efforts, either within a single system or through cross-sector partnerships, to enhance the utilization of existing data. The primary purpose is to drive prediction and real-time proactive responses to the overdose crisis. These projects will promote the synthesis and real-world application of data to guide and monitor improvements in service delivery for preventing or treating opioid use disorder (OUD) and pain. The initiative addresses critical gaps in evidence-based practices across primary prevention, harm reduction, OUD treatment, and recovery support, aligning with the HHS Overdose Prevention Strategy.
Opportunity ID: 343690
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-23-057 |
| Funding Opportunity Title: | HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 21, 2022 |
| Last Updated Date: | Sep 21, 2022 |
| Original Closing Date for Applications: | Nov 22, 2022 |
| Current Closing Date for Applications: | Nov 22, 2022 |
| Archive Date: | Dec 28, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $750,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Small businesses State governments For profit organizations other than small businesses City or township governments County governments Private institutions of higher education Special district governments Public and State controlled institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | As part of the NIH HEAL Initiative, the National Institute on Drug Abuse (NIDA) is releasing a set of interrelated RFAs to create the HEAL Data2Action (D2A) Program, a coordinated effort to promote the synthesis and real-world application of existing data to guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will address gaps in the delivery of evidence-based practices in each of the four pillars of the HHS Overdose Prevention Strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support. Separate FOAs are being issued to support multiple HEAL D2A Innovation Projects (RFA-DA-22-051); one HEAL D2A Data Infrastructure Support Center (RFA-DA-22-052); one HEAL D2A Research Adoption Support Center (RFA-DA-22-050); and one HEAL D2A Economics and Modeling Resource Center (RFA-DA-22-049). It is imperative that prospective applicants read all of these related RFAs to better understand the intended purpose and structure of the HEAL D2A Program.This FOA solicits applications for HEAL D2A Innovation Projects, which are phased awards intended to support local efforts, either within a single system or in cross-sector partnerships, to improve utilization of data to drive prediction and real-time proactive responses to the overdose crisis. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-057.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 343690 Full Announcement-RFA-DA-23-057 -> RFA-DA-23-057-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00276906 | Oct 22, 2022 | Nov 22, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278387 | Nov 14, 2022 | Nov 22, 2022 | View |
Package 1
Mandatory forms
343690 RR_SF424_5_0-5.0.pdf
343690 PHS398_CoverPageSupplement_5_0-5.0.pdf
343690 RR_OtherProjectInfo_1_4-1.4.pdf
343690 PerformanceSite_4_0-4.0.pdf
343690 RR_KeyPersonExpanded_4_0-4.0.pdf
343690 RR_Budget_3_0-3.0.pdf
343690 PHS398_ResearchPlan_4_0-4.0.pdf
343690 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343690 RR_SubawardBudget30_3_0-3.0.pdf
343690 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343690 RR_SF424_5_0-5.0.pdf
343690 PHS398_CoverPageSupplement_5_0-5.0.pdf
343690 RR_OtherProjectInfo_1_4-1.4.pdf
343690 PerformanceSite_4_0-4.0.pdf
343690 RR_KeyPersonExpanded_4_0-4.0.pdf
343690 RR_Budget_3_0-3.0.pdf
343690 PHS398_ResearchPlan_5_0-5.0.pdf
343690 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343690 RR_SubawardBudget30_3_0-3.0.pdf
343690 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
